Literature DB >> 20157021

Successful treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir.

Leslie Castelo-Soccio1, Ronald Bernardin, John Stern, Stephen A Goldstein, Carrie Kovarik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20157021      PMCID： PMC2874880          DOI： 10.1001/archdermatol.2009.363

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  12 in total

Review 1.  Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature.

Authors:  S Cha; L Johnston; Y Natkunam; J Brown
Journal:  Transpl Infect Dis       Date:  2005 Sep-Dec       Impact factor: 2.228

2.  Intralesional cidofovir does not increase the risk of laryngeal dysplasia or laryngeal carcinoma.

Authors:  Frederik G Dikkers
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2008-07-03       Impact factor: 1.675

3.  Bioavailability and metabolism of cidofovir following topical administration to rabbits.

Authors:  K C Cundy; G Lynch; W A Lee
Journal:  Antiviral Res       Date:  1997-07       Impact factor: 5.970

4.  Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection.

Authors:  Margaret D Kottke; Sareeta R S Parker
Journal:  J Am Acad Dermatol       Date:  2006-09       Impact factor: 11.527

5.  Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.

Authors:  K C Cundy; A M Bidgood; G Lynch; J P Shaw; L Griffin; W A Lee
Journal:  Drug Metab Dispos       Date:  1996-07       Impact factor: 3.922

6.  Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug.

Authors:  K C Cundy; Z H Li; M J Hitchcock; W A Lee
Journal:  Drug Metab Dispos       Date:  1996-07       Impact factor: 3.922

Review 7.  Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.

Authors:  Jorge R Toro; Samuel Sanchez; George Turiansky; Andrew Blauvelt
Journal:  Dermatol Clin       Date:  2003-04       Impact factor: 3.478

Review 8.  Management of acyclovir-resistant herpes simplex virus.

Authors:  Suneel Chilukuri; Ted Rosen
Journal:  Dermatol Clin       Date:  2003-04       Impact factor: 3.478

Review 9.  Cidofovir: to use or not to use?

Authors:  Marlene A Soma; David M Albert
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2008-02       Impact factor: 2.064

Review 10.  Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.

Authors:  Ferdinand I Broekema; Frederik G Dikkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-06       Impact factor: 2.503
View more
  11 in total

Review 1.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

Review 2.  HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

Authors:  Khatiya Chelidze; Cristina Thomas; Aileen Yenting Chang; Esther Ellen Freeman
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

3.  Complex management of resistant oral herpes simplex virus infection following hematopoietic stem cell transplantation: potential role of topical cidofovir.

Authors:  Joel B Epstein; Sara Gharapetian; Ali R Rejali; Rachel Zabner; Michael Lill; Dimitrios Tzachanis
Journal:  Support Care Cancer       Date:  2016-05-10       Impact factor: 3.603

4.  Surgical excision for recurrent herpes simplex virus 2 (HSV-2) anogenital infection in a patient with human immunodeficiency virus (HIV).

Authors:  Folasade Arinze; Aaron Shaver; Stephen Raffanti
Journal:  Infection       Date:  2017-05-15       Impact factor: 3.553

5.  Viral Venereal Diseases of the Skin.

Authors:  Theodora K Karagounis; Miriam K Pomeranz
Journal:  Am J Clin Dermatol       Date:  2021-05-18       Impact factor: 7.403

6.  First Impressions-the Potential of Altering Initial Host-Virus Interactions for Rational Design of Herpesvirus Vaccine Vectors.

Authors:  Paul J F Rider; Farhana Musarrat; Rafiq Nabil; Shan Naidu; Konstantin G Kousoulas
Journal:  Curr Clin Microbiol Rep       Date:  2018-01-27

7.  Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus -1: an in vitro study on virally infected Vero and MRC-5 cell lines.

Authors:  Rand R Hafidh; Ahmed S Abdulamir; Fatimah Abu Bakar; Zamberi Sekawi; Fatemeh Jahansheri; Farid Azizi Jalilian
Journal:  BMC Complement Altern Med       Date:  2015-06-11       Impact factor: 3.659

8.  Isolation and identification of compounds from Kalanchoe pinnata having human alphaherpesvirus and vaccinia virus antiviral activity.

Authors:  Matthew Cryer; Kyle Lane; Mary Greer; Rex Cates; Scott Burt; Merritt Andrus; Jiping Zou; Paul Rogers; Marc D H Hansen; Jillybeth Burgado; Subbian Satheshkumar Panayampalli; Craig W Day; Donald F Smee; Brent F Johnson
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

9.  Treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir.

Authors:  Christina D Enescu; Sarah Utz Petry; Nathan Nartker; Meena Moossavi
Journal:  JAAD Case Rep       Date:  2021-05-26

Review 10.  New strategies against drug resistance to herpes simplex virus.

Authors:  Yu-Chen Jiang; Hui Feng; Yu-Chun Lin; Xiu-Rong Guo
Journal:  Int J Oral Sci       Date:  2016-03-30       Impact factor: 6.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.